
Profile
General Information
Morton Grove Pharmaceuticals' Clindamycin Phosphate Topical Solution USP 1%, an antibiotic for the treatment of acne vulgaris, has been approved by the FDA. According to the FDA approval letter, Morton Grove Pharmaceuticals' product was found to be equivalent to CLEOCIN Topical Solution 1%, marketed by Pharmacia & Upjohn Company.
Approval Date: 1997-07-01
Company Name: Morton Grove Pharmaceuticals